RAD52 and skin squamous cell carcinoma: In the dominant genetic models, the rs1051669 variant AG/AA carriers showed a significantly decreased expression level of RAD52 protein in CSCC patients, compared with variant GG genotype carriers [logistic regression analysis, adjusted odds ratio (OR) = 4.7, 95% confidence interval (CI) = 1.4–16.1, P = 0.013; Table 3].